These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19540329)

  • 41. Synthesis of isoquinuclidine analogs of chloroquine: antimalarial and antileishmanial activity.
    Khan MO; Levi MS; Tekwani BL; Wilson NH; Borne RF
    Bioorg Med Chem; 2007 Jun; 15(11):3919-25. PubMed ID: 17400457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum.
    Bray PG; Hawley SR; Mungthin M; Ward SA
    Mol Pharmacol; 1996 Dec; 50(6):1559-66. PubMed ID: 8967978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico design, chemical synthesis and biological screening of novel 4-(1H)-pyridone-based antimalarial agents.
    Audu O; Stander A; Ajani O; Egieyeh S; October N
    Chem Biol Drug Des; 2022 May; 99(5):674-687. PubMed ID: 34850571
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development.
    Casartelli A; Bonato M; Cristofori P; Crivellente F; Dal Negro G; Masotto I; Mutinelli C; Valko K; Bonfante V
    Cell Biol Toxicol; 2003 Jun; 19(3):161-76. PubMed ID: 12945744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, structural characterization and biological evaluation of novel stilbene derivatives as potential antimalarial agents.
    Jung M; Park WH; Jung JC; Lim E; Lee Y; Oh S; Moon HI
    Chem Biol Drug Des; 2009 Mar; 73(3):346-54. PubMed ID: 19207471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyridinium cationic-dimer antimalarials, unlike chloroquine, act selectively between the schizont stage and the ring stage of Plasmodium falciparum.
    Yoshikawa M; Motoshima K; Fujimoto K; Tai A; Kakuta H; Sasaki K
    Bioorg Med Chem; 2008 Jun; 16(11):6027-33. PubMed ID: 18479926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and antimalarial activity of carbamate and amide derivatives of 4-anilinoquinoline.
    Delarue-Cochin S; Grellier P; Maes L; Mouray E; Sergheraert C; Melnyk P
    Eur J Med Chem; 2008 Oct; 43(10):2045-55. PubMed ID: 18226428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess antimalarial activity.
    Chen X; Chong CR; Shi L; Yoshimoto T; Sullivan DJ; Liu JO
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14548-53. PubMed ID: 16983082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of pyridone-containing imidazolines as potent and selective inhibitors of neuropeptide Y Y5 receptor.
    Ando M; Sato N; Nagase T; Nagai K; Ishikawa S; Takahashi H; Ohtake N; Ito J; Hirayama M; Mitobe Y; Iwaasa H; Gomori A; Matsushita H; Tadano K; Fujino N; Tanaka S; Ohe T; Ishihara A; Kanatani A; Fukami T
    Bioorg Med Chem; 2009 Aug; 17(16):6106-22. PubMed ID: 19616955
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoquaternary ammonium derivatives inhibit growth of protozoan parasites.
    Bahamontes-Rosa N; Robin A; Ambrosio AR; Messias-Reason I; Beitz E; Flitsch SL; Kun JF
    Parasitol Int; 2008 Jun; 57(2):132-7. PubMed ID: 17980650
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploration of a new type of antimalarial compounds based on febrifugine.
    Kikuchi H; Yamamoto K; Horoiwa S; Hirai S; Kasahara R; Hariguchi N; Matsumoto M; Oshima Y
    J Med Chem; 2006 Jul; 49(15):4698-706. PubMed ID: 16854076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overview: clinical pharmacology of antimalarials.
    Karbwang J; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation.
    Matsuzaki K; Murase O; Fujii N; Miyajima K
    Biochemistry; 1996 Sep; 35(35):11361-8. PubMed ID: 8784191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmodium falciparum: selenium-induced cytotoxicity to P. falciparum.
    Taguchi N; Hatabu T; Yamaguchi H; Suzuki M; Sato K; Kano S
    Exp Parasitol; 2004; 106(1-2):50-5. PubMed ID: 15013789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue.
    Biot C; Glorian G; Maciejewski LA; Brocard JS
    J Med Chem; 1997 Nov; 40(23):3715-8. PubMed ID: 9371235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-induced phospholipidosis.
    Anderson N; Borlak J
    FEBS Lett; 2006 Oct; 580(23):5533-40. PubMed ID: 16979167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development.
    Loryan I; Hoppe E; Hansen K; Held F; Kless A; Linz K; Marossek V; Nolte B; Ratcliffe P; Saunders D; Terlinden R; Wegert A; Welbers A; Will O; Hammarlund-Udenaes M
    Mol Pharm; 2017 Dec; 14(12):4362-4373. PubMed ID: 29099189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.